Ninth Revision, Clinical Modification codes for CLABSI reporting: University of Michigan C. S. Mott Children' s Hospital, Monroe Carell Jr Children' s Hospital at Vanderbilt, and Seattle Children' s Hospital. 14, 16 All patient discharges from January 1, 2008, to December 31, 2010, for the 3 hospitals were submitted to the Children' s Hospital Association Comparative Case Mix Data Program through a standard universal billing submission process by using CDC/National Network criteria. 16, 17 Data analysis was only for 2010.
Denominator Stratification
CRGs were used to stratify the study population according to condition complexities to determine CLABSI rates. CRG methodology has been previously described. 11 CRGs stratify patients into 9 hierarchical, mutually exclusive health status groups: (1) nonchronic acute, (2) nonchronic significant acute, (3) minor chronic, (4) multiple minor chronic, (5) moderate chronic or dominant chronic in only 1 body system, (6) moderate chronic or dominant chronic in 2 body systems, (7) dominant chronic in $3 body systems, (8) malignancies in active therapy, and (9) catastrophic, including conditions that are progressive, solid organ transplantation, or long-term dependency on technology.
For the purposes of this study, the CRG status groups were further combined into the following 5 study groups that matched the CRG hierarchy: The CRG software used hospital discharge data from 3 years (2008, 2009 , and 2010) to assign each individual patient hospitalized in 2010 to a single hierarchical CRG status group based on the complexity of that individual' s underlying health conditions. The CRG status group assignment was then combined in a nonduplicate fashion to 1 of the 5 study groups and then divided further into those ,1 and $1 year before examining CLABSI rates.
The percentage of hospitalizations with CLABSIs were calculated for each of the 5 study groups; x 2 analyses and Fisher' s exact tests were performed to identify statistical differences between the rates of infection of the different groups.
RESULTS
The 3 institutions in 2010 had 35 687 patient discharges and 138 CLABSIs. The overall CLABSI rate was 0.387%. There are significant variations in rates according to CRG status, ranging from 0.008% (1/13 219) for study group 1, nonchronic, to 1.604% (59/3678) for study group 5, progressive chronic or dependent on technology. Rates increased between each CRG study group: study group 2, noncomplex chronic 0.134% (14/10 472); study group 3, complex chronic 0.625% (38/6081); and study group 4, malignancies 1.162% (26/2237), and were significantly different from each other (P , .05) with the exception between study group 4, malignancies 1.162% (26/2237), and study group 5, progressive chronic or dependent on technology 1.604% (59/3678) (P 5 .178) (Fig 1) .
For patients younger than 1 year, there were 13 991 discharges and 74 CLABSIs, an overall CLABSI rate of 0.529%. There was significant variation across the CRG study groups, ranging from 0.011% (1/9237) for study group 1, nonchronic, to 4.264% (31/727) for study group 5, progressive chronic or dependent on technology. Rates were significantly different from each other and increased between each study group (P , .05): study group 2, noncomplex chronic 0.473% (12/2539); study group 3, complex chronic 1.959% (28/1429); study group 4, malignancies 3.390% (2/59), except in 2 instances between study group 4, malignancies 3.39% (2/59), and study group 5, progressive chronic or dependent on technology 4.264% (31/727) (P 5 1.00), and between study group 3, complex chronic 1.959% (28/1429), and study group 4, malignancies 3.39% (2/59) (P 5 .335).
For patients $1 year who were hospitalized in 2010 (Fig 1) , there were 21 696 discharges and 64 CLABSIs, for an overall CLABSI rate of 0.295%. This rate was lower than for patients ,1 year but generally followed the same pattern across CRG study groups. Rates ranged from 0.0% (0/3982) for study group 1, nonchronic, to 0.949% (28/2951) for study group 5, progressive chronic or dependent on technology, with the CLABSI rate for study group 4, malignancies, being highest at 1.102% (24/2178). Rates increased between each status group: study group 2, noncomplex chronic 0.025% (2/7933); study group 3, complex chronic 0.215% (10/4652); study group 4, malignancies, 1.102% (24/2178). Most comparisons between CRG groups were significantly different from each other (most P , .001), with the exceptions between study group 4, malignancies 1.102% (24/2178), and study group 5, progressive chronic or dependent on technology 0.949% (28/2951) (P 5 .69), and between, study group 1, nonchronic 0.0% (0/3982) and complex chronic 0.025% (10/4652) (P 5 .44).
DISCUSSION
The measurement of hospital CLABSI rates have been used primarily for performance improvement, not public reporting. Now a number of states have legislation requiring public reports of infection rates. 18 This focus on CLABSI highlights the need to make sure hospital reports are adequately risk adjusted to control for patient characteristics. Line days is a commonly practiced way to measure the risk of CLABSI, but has not been adapted for general use in administrative data. Cataloging central line days is a burdensome process when the information is collected manually. Other methods of stratification have not been evaluated. Recent studies point to both extrinsic potentially modifiable factors, and intrinsic nonmodifiable factors influencing CLABSI rates. [19] [20] [21] The duration, placement, and number of central lines are extrinsic risk factors, items that providers can potentially alter to lower the risk of infection during line insertion or maintenance. A patient' s age and underlying disease conditions are intrinsic risk factors, patient characteristics that are generally not modifiable by the provider. Although line days may vary according to provider practices, the underlying conditions are a consistent measurement of susceptibility. Payment programs could account for the variations in patients according to age and underlying conditions.
In this study, we demonstrated how patient complexity groups and age can be used to provide statistically significant rates for CLABSI. CRGs can risk adjust to specific clinical subgroups but that will need to be the focus of future studies. Children ,1 year in this study population of 3 tertiary care children' s hospitals had significantly higher rates of CLABSI (0.529%) compared with those $1 (0.295%), paralleling a previous study looking at all complications of surgical central lines. 22 This is reflected in all of the chronic condition groups. In both those ,1 and $1 year, the rates of CLABSI are highest in the 2 study groups of malignancies (study group 4) and progressive chronic and dependent on technology (study group 5).
The strengths of this study are that we demonstrated a novel way of measuring the risk of CLABSI in children that reflects the complexity of conditions admitted to a children' s hospital. This could provide an accurate way of measuring the risk of CLABSI in lieu of patient line days. The limitations of this study are as follows. (1) The 3 children' s hospitals selected for this study may not be representative. These hospitals are similar teaching hospitals that accept referrals from large geographic areas. They performed significant numbers of central line placements and used CDCvalidated CLABSI reports. 14 For the next steps, we recommend a study that compares a chronic condition risk adjustment tool and age stratification to line days and admission to ICUs in a large multihospital data set.
CONCLUSIONS
In this study we examined the rates of CLABSI in 3 children' s hospitals according to age ,1 and $1 year and patient complexity groups by using the 3M CRGs. Children' s hospitals care for a large population of children with many complex chronic conditions, a group at higher susceptibility to CLABSI. Our study illustrates the use of a risk adjustment tool in determining CLABSI rates for public reporting or pay for performance. The use of a risk adjustment strategy focusing on a patient' s underlying condition and age group could be a method to report provider performance in the absence of reported line days in administrative data.
